These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19519393)
21. Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series: synthesis and biological behaviour. Top S; Vessières A; Pigeon P; Rager MN; Huché M; Salomon E; Cabestaing C; Vaissermann J; Jaouen G Chembiochem; 2004 Aug; 5(8):1104-13. PubMed ID: 15300835 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of 4,4'-Diaminotriphenylmethanes with Potential Selective Estrogen Receptor Modulator (SERM)-like Activity. Guedes G; Amesty Á; Jiménez-Monzón R; Marrero-Alonso J; Díaz M; Fernández-Pérez L; Estévez-Braun A ChemMedChem; 2015 Aug; 10(8):1403-12. PubMed ID: 26076185 [TBL] [Abstract][Full Text] [Related]
23. Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer. Fuqua SA; Russo J; Shackney SE; Stearns ME Postgrad Med; 2001 Mar; Spec No():3-10. PubMed ID: 11296736 [TBL] [Abstract][Full Text] [Related]
24. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator. Zhang JX; Labaree DC; Mor G; Hochberg RB J Clin Endocrinol Metab; 2004 Jul; 89(7):3527-35. PubMed ID: 15240642 [TBL] [Abstract][Full Text] [Related]
26. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms. Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and preliminary biological evaluation of new carbon-11 labeled tetrahydroisoquinoline derivatives as SERM radioligands for PET imaging of ER expression in breast cancer. Gao M; Wang M; Miller KD; Sledge GW; Zheng QH Eur J Med Chem; 2008 Oct; 43(10):2211-9. PubMed ID: 18272256 [TBL] [Abstract][Full Text] [Related]
28. Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells. Jackson A; Davis J; Pither RJ; Rodger A; Hannon MJ Inorg Chem; 2001 Jul; 40(16):3964-73. PubMed ID: 11466055 [TBL] [Abstract][Full Text] [Related]
29. Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. Patel HK; Bihani T Pharmacol Ther; 2018 Jun; 186():1-24. PubMed ID: 29289555 [TBL] [Abstract][Full Text] [Related]
30. Detection of Endogenous Selective Estrogen Receptor Modulators such as 27-Hydroxycholesterol. Nelson ER Methods Mol Biol; 2016; 1366():431-443. PubMed ID: 26585155 [TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. Dutertre M; Smith CL J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073 [TBL] [Abstract][Full Text] [Related]
32. Selective modulation of sex steroids. Goldstein JS; Sites CK Ageing Res Rev; 2002 Feb; 1(1):17-28. PubMed ID: 12039446 [TBL] [Abstract][Full Text] [Related]
33. Characterization of selective estrogen receptor modulator (SERM) activity in two triarylethylene oxybutyric acids. Rubin VN; Ruenitz PC; Boyd JL; Boudinot FD; Wiese TE Biochem Pharmacol; 2002 Apr; 63(8):1517-25. PubMed ID: 11996894 [TBL] [Abstract][Full Text] [Related]
34. Capitalizing on the complexities of estrogen receptor pharmacology in the quest for the perfect SERM. McDonnell DP; Chang CY; Norris JD Ann N Y Acad Sci; 2001 Dec; 949():16-35. PubMed ID: 11795348 [TBL] [Abstract][Full Text] [Related]
35. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha. Aliau S; Mattras H; Richard E; Bonnafous JC; Borgna JL Biochemistry; 2002 Jun; 41(25):7979-88. PubMed ID: 12069588 [TBL] [Abstract][Full Text] [Related]
36. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Härkönen PL; Väänänen HK Ann N Y Acad Sci; 2006 Nov; 1089():218-27. PubMed ID: 17261769 [TBL] [Abstract][Full Text] [Related]
37. Selective estrogen receptor modulators: an update on recent clinical findings. Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543 [TBL] [Abstract][Full Text] [Related]
38. The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer. Liby K; Rendi M; Suh N; Royce DB; Risingsong R; Williams CR; Lamph W; Labrie F; Krajewski S; Xu X; Kim H; Brown P; Sporn MB Clin Cancer Res; 2006 Oct; 12(19):5902-9. PubMed ID: 17020999 [TBL] [Abstract][Full Text] [Related]
39. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast. Pickar JH; Komm BS Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, antiproliferative and pro-apoptotic activity of 2-phenylindoles. Kelly PM; Bright SA; Fayne D; Pollock JK; Zisterer DM; Williams DC; Meegan MJ Bioorg Med Chem; 2016 Sep; 24(18):4075-4099. PubMed ID: 27407030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]